Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Velasco Santiago M"'
Autor:
Mola-Velasco, Santiago M.
Wikipedia is an online encyclopedia that anyone can edit. In this open model, some people edits with the intent of harming the integrity of Wikipedia. This is known as vandalism. We extend the framework presented in (Potthast, Stein, and Gerling, 200
Externí odkaz:
http://arxiv.org/abs/1210.5560
Publikováno v:
eHealth, Care & Quality of Life; 2014, p175-184, 10p
Autor:
Mola-Velasco, Santiago M.
Publikováno v:
Proceedings of the 20th International Conference Companion: World Wide Web; 3/28/2011, p391-396, 6p
Publikováno v:
Computational Linguistics & Intelligent Text Processing (9783642194368); 2011, p277-288, 12p
Autor:
Ascic E; Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, 221 84 Lund, Sweden.; Wallenberg Centre for Molecular Medicine at Lund University, 221 84 Lund, Sweden., Åkerström F; Asgard Therapeutics AB, Medicon Village, 223 81 Lund, Sweden., Sreekumar Nair M; Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, 221 84 Lund, Sweden.; Wallenberg Centre for Molecular Medicine at Lund University, 221 84 Lund, Sweden., Rosa A; Asgard Therapeutics AB, Medicon Village, 223 81 Lund, Sweden., Kurochkin I; Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, 221 84 Lund, Sweden.; Wallenberg Centre for Molecular Medicine at Lund University, 221 84 Lund, Sweden., Zimmermannova O; Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, 221 84 Lund, Sweden.; Wallenberg Centre for Molecular Medicine at Lund University, 221 84 Lund, Sweden., Catena X; Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, 221 84 Lund, Sweden.; Wallenberg Centre for Molecular Medicine at Lund University, 221 84 Lund, Sweden.; Asgard Therapeutics AB, Medicon Village, 223 81 Lund, Sweden., Rotankova N; InSphero AG, 8952 Schlieren, Switzerland., Veser C; InSphero AG, 8952 Schlieren, Switzerland., Rudnik M; InSphero AG, 8952 Schlieren, Switzerland., Ballocci T; Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, 221 84 Lund, Sweden.; Wallenberg Centre for Molecular Medicine at Lund University, 221 84 Lund, Sweden., Schärer T; Asgard Therapeutics AB, Medicon Village, 223 81 Lund, Sweden., Huang X; Asgard Therapeutics AB, Medicon Village, 223 81 Lund, Sweden., de Rosa Torres M; Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, 221 84 Lund, Sweden.; Wallenberg Centre for Molecular Medicine at Lund University, 221 84 Lund, Sweden., Renaud E; Asgard Therapeutics AB, Medicon Village, 223 81 Lund, Sweden., Velasco Santiago M; Department of Oncology, National Center of Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, 2730 Herlev, Denmark., Met Ö; Department of Oncology, National Center of Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, 2730 Herlev, Denmark.; Department of Health Technology, Technical University of Denmark, 2800 Kongens Lyngby, Denmark., Askmyr D; Department of Otorhinolaryngology, Head & Neck Surgery, Skåne University Hospital, 221 85 Lund, Sweden.; Department of Clinical Sciences, Lund University, 221 84 Lund, Sweden., Lindstedt M; Department of Immunotechnology, Lund University, Medicon Village, 223 81 Lund, Sweden., Greiff L; Department of Otorhinolaryngology, Head & Neck Surgery, Skåne University Hospital, 221 85 Lund, Sweden.; Department of Clinical Sciences, Lund University, 221 84 Lund, Sweden., Ligeon LA; InSphero AG, 8952 Schlieren, Switzerland., Agarkova I; InSphero AG, 8952 Schlieren, Switzerland., Svane IM; Department of Oncology, National Center of Cancer Immune Therapy (CCIT-DK), Copenhagen University Hospital, 2730 Herlev, Denmark., Pires CF; Asgard Therapeutics AB, Medicon Village, 223 81 Lund, Sweden., Rosa FF; Asgard Therapeutics AB, Medicon Village, 223 81 Lund, Sweden., Pereira CF; Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, 221 84 Lund, Sweden.; Wallenberg Centre for Molecular Medicine at Lund University, 221 84 Lund, Sweden.; Asgard Therapeutics AB, Medicon Village, 223 81 Lund, Sweden.; Centre for Neuroscience and Cell Biology, University of Coimbra, Largo Marquês do Pombal, 3004-517 Coimbra, Portugal.
Publikováno v:
Science (New York, N.Y.) [Science] 2024 Oct 18; Vol. 386 (6719), pp. eadn9083. Date of Electronic Publication: 2024 Oct 18.
Autor:
Zimmermannova O; Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, BMC A12, 221 84 Lund, Sweden.; Wallenberg Center for Molecular Medicine at Lund University, BMC A12, 221 84 Lund, Sweden., Ferreira AG; Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, BMC A12, 221 84 Lund, Sweden.; Wallenberg Center for Molecular Medicine at Lund University, BMC A12, 221 84 Lund, Sweden.; CNC-Centre for Neuroscience and Cell Biology, University of Coimbra, Largo Marquês do Pombal, 3004-517 Coimbra, Portugal.; Doctoral Programme in Experimental Biology and Biomedicine, University of Coimbra, Largo Marquês do Pombal, 3004-517 Coimbra, Portugal., Ascic E; Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, BMC A12, 221 84 Lund, Sweden.; Wallenberg Center for Molecular Medicine at Lund University, BMC A12, 221 84 Lund, Sweden., Velasco Santiago M; National Center of Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Borgmester Ib Juuls Vej 1, 2730 Herlev, Denmark., Kurochkin I; Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, BMC A12, 221 84 Lund, Sweden.; Wallenberg Center for Molecular Medicine at Lund University, BMC A12, 221 84 Lund, Sweden., Hansen M; National Center of Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Borgmester Ib Juuls Vej 1, 2730 Herlev, Denmark., Met Ö; National Center of Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Borgmester Ib Juuls Vej 1, 2730 Herlev, Denmark.; Department of Health Technology, Technical University of Denmark, Ørsteds Pl. 345C, 2800 Kongens Lyngby, Denmark., Caiado I; Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, BMC A12, 221 84 Lund, Sweden.; Wallenberg Center for Molecular Medicine at Lund University, BMC A12, 221 84 Lund, Sweden.; CNC-Centre for Neuroscience and Cell Biology, University of Coimbra, Largo Marquês do Pombal, 3004-517 Coimbra, Portugal.; Doctoral Programme in Experimental Biology and Biomedicine, University of Coimbra, Largo Marquês do Pombal, 3004-517 Coimbra, Portugal., Shapiro IE; Ludwig Institute for Cancer Research, Lausanne Branch-University of Lausanne (UNIL), Rue du Bugnon 46, CH-1011 Lausanne, Switzerland.; Department of Oncology-University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Rue du Bugnon 46, CH-1011 Lausanne, Switzerland., Michaux J; Ludwig Institute for Cancer Research, Lausanne Branch-University of Lausanne (UNIL), Rue du Bugnon 46, CH-1011 Lausanne, Switzerland.; Department of Oncology-University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Rue du Bugnon 46, CH-1011 Lausanne, Switzerland., Humbert M; Department of Pathology and Immunology, Geneva Medical School, Av. de Champel 41, 1206 Geneva, Switzerland.; Center for Infectious Medicine, Huddinge Hospital, Karolinska Institutet, Alfred Nobels Allé 8, 141 52 Huddinge, Sweden., Soto-Cabrera D; Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, BMC A12, 221 84 Lund, Sweden.; Wallenberg Center for Molecular Medicine at Lund University, BMC A12, 221 84 Lund, Sweden., Benonisson H; Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, BMC A12, 221 84 Lund, Sweden.; Wallenberg Center for Molecular Medicine at Lund University, BMC A12, 221 84 Lund, Sweden., Silvério-Alves R; Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, BMC A12, 221 84 Lund, Sweden.; Wallenberg Center for Molecular Medicine at Lund University, BMC A12, 221 84 Lund, Sweden.; CNC-Centre for Neuroscience and Cell Biology, University of Coimbra, Largo Marquês do Pombal, 3004-517 Coimbra, Portugal.; Doctoral Programme in Experimental Biology and Biomedicine, University of Coimbra, Largo Marquês do Pombal, 3004-517 Coimbra, Portugal., Gomez-Jimenez D; Department of Immunotechnology, Lund University, Medicon Village, Scheelevägen 2, 223 81 Lund, Sweden., Bernardo C; Division of Oncology, Department of Clinical Sciences, Lund, Medicon Village, Scheelevägen 2, 223 81 Lund, Sweden., Bauden M; Department of Surgery, Clinical Sciences Lund, Lund University, Skåne University Hospital, 221 85 Lund, Sweden., Andersson R; Department of Surgery, Clinical Sciences Lund, Lund University, Skåne University Hospital, 221 85 Lund, Sweden., Höglund M; Division of Oncology, Department of Clinical Sciences, Lund, Medicon Village, Scheelevägen 2, 223 81 Lund, Sweden., Miharada K; Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, BMC A12, 221 84 Lund, Sweden.; International Research Center for Medical Sciences, Kumamoto University, 2-2-1 Honjo, Chuo-Ku, Kumamoto 860-0811, Japan., Nakamura Y; Cell Engineering Division, RIKEN BioResource Research Center, 3-1-1 Koyadai, 305-0074, Tsukuba, Ibaraki, Japan., Hugues S; Department of Pathology and Immunology, Geneva Medical School, Av. de Champel 41, 1206 Geneva, Switzerland., Greiff L; Department of ORL, Head and Neck Surgery, Skåne University Hospital, 221 85 Lund, Sweden.; Department of Clinical Sciences, Lund University, 221 84 Lund, Sweden., Lindstedt M; Department of Immunotechnology, Lund University, Medicon Village, Scheelevägen 2, 223 81 Lund, Sweden., Rosa FF; Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, BMC A12, 221 84 Lund, Sweden.; Wallenberg Center for Molecular Medicine at Lund University, BMC A12, 221 84 Lund, Sweden.; Asgard Therapeutics AB, Medicon Village, 223 81 Lund, Sweden., Pires CF; Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, BMC A12, 221 84 Lund, Sweden.; Wallenberg Center for Molecular Medicine at Lund University, BMC A12, 221 84 Lund, Sweden.; Asgard Therapeutics AB, Medicon Village, 223 81 Lund, Sweden., Bassani-Sternberg M; Ludwig Institute for Cancer Research, Lausanne Branch-University of Lausanne (UNIL), Rue du Bugnon 46, CH-1011 Lausanne, Switzerland.; Department of Oncology-University of Lausanne (UNIL) and Lausanne University Hospital (CHUV), Rue du Bugnon 46, CH-1011 Lausanne, Switzerland., Svane IM; National Center of Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Borgmester Ib Juuls Vej 1, 2730 Herlev, Denmark., Pereira CF; Molecular Medicine and Gene Therapy, Lund Stem Cell Centre, Lund University, BMC A12, 221 84 Lund, Sweden.; Wallenberg Center for Molecular Medicine at Lund University, BMC A12, 221 84 Lund, Sweden.; CNC-Centre for Neuroscience and Cell Biology, University of Coimbra, Largo Marquês do Pombal, 3004-517 Coimbra, Portugal.; Asgard Therapeutics AB, Medicon Village, 223 81 Lund, Sweden.
Publikováno v:
Science immunology [Sci Immunol] 2023 Jul 14; Vol. 8 (85), pp. eadd4817. Date of Electronic Publication: 2023 Jul 07.